|
Volumn 19 Suppl 2, Issue , 2009, Pages
|
Trials with impact on clinical management: first line.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADJUVANT THERAPY;
DISEASE COURSE;
EVALUATION;
FEMALE;
HUMAN;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
NEOPLASM;
OVARY TUMOR;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL;
PRACTICE GUIDELINE;
REVIEW;
STANDARD;
CLINICAL TRIALS, PHASE III AS TOPIC;
COMBINED MODALITY THERAPY;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
NEOADJUVANT THERAPY;
NEOPLASMS, GLANDULAR AND EPITHELIAL;
OVARIAN NEOPLASMS;
PRACTICE GUIDELINES AS TOPIC;
MLCS;
MLOWN;
|
EID: 77950361629
PISSN: None
EISSN: 15251438
Source Type: Journal
DOI: 10.1111/igc.0b013e3181c36ea0 Document Type: Review |
Times cited : (21)
|
References (75)
|